Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
Future treatment approaches to multiple sclerosis.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Street-experienced peripheral B cells traffic to the brain.
Promoting physical activity to control multiple sclerosis from childhood.
Modulators of Microglia: a Patent Review.
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
ISENTRESS® prescribing information
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
Epileptic Seizures in Early-onset Multiple Sclerosis.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
Fluctuations of MS births and UV-light exposure.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Remission with fingolimod in a case of demyelinating polyneuropathy.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.

Pages